13 studies on Humanin curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab indexes 29 published Humanin COA source records from third-party laboratories, covering 17 publicly attributable vendor identities. Across 21 records with positive numeric purity, the arithmetic mean is 96.1%. 0 records report zero purity; these remain in the record count and are excluded from the positive-purity mean. 1 positive purity results are below 90%; 5 records report measured amount more than 10% below the label. The latest recorded test date is 2026-10-08. TitrateLab did not perform these laboratory tests. Source records are not unique batches, and vendor identity does not establish manufacturing role, product safety or overall quality.
All published source records, including absent and zero purity. Matching uses a case-insensitive exact peptide token. No deduplication in the headline; vendor rankings deduplicate eligible certificates separately. The COA archive can use normalized compound names and a different measurement or duplicate policy; totals from these populations need not match.
Latest recorded test: 2026-10-08. Aggregate calculated: 2026-10-18T04:26:01.436401+00:00. Calculation time is not a laboratory observation date.
Within that total, 10 source records have unresolved vendor identity. They remain in corpus-level lab evidence and are excluded from named-vendor rankings.
Eligible vendors have at least 2 deduplicated certificates and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and certificate count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes submitted-sample evidence, not every product or shipment, and is not an endorsement.
| Rank | Vendor | Deduplicated certificates | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 2 | 97.91% | 0 of 2 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → |
Vendor identities are included with Pro. Record counts and lab measurements remain visible.
Recent source records: #118746 · #91228 (99.19%) · #117896 (99.36%) · #80472 (91.298%) · #80470 (91.298%) · #74788 (94.542%)
This study suggests that **Humanin** could offer a novel therapeutic strategy for managing **Diabetes mellitus** by addressing the underlying hormonal dysregulation beyond just glucose control. For peptide users and b…
This research highlights **Humanin** as a potential therapeutic agent for **Age-related macular degeneration (AMD)** by directly addressing **mitochondrial dysfunction** in the **RPE**. **Targeting mitophagy** with **…
Allogeneic Mitochondria and Associated Organelle Complex (AMOC) treatment prevents myocardial ischemia-reperfusion injury by exerting anti-apoptotic effects.
This study suggests **Humanin-G could be a promising therapeutic agent for retinal degeneration**, offering a novel approach to preserve visual function. For individuals exploring peptide-based interventions for ocula…
**Understanding Piezo-CAP's precise mechanisms on neurogenesis opens new avenues for regenerative medicine and neurological disorder treatment.** This research moves beyond simply observing effects to exploring the `c…
<b>Humanin-G's potential to protect retinal cells could offer a new strategy for treating degenerative eye diseases.</b> If future research confirms HNG's efficacy, it could represent a significant advancement for ind…
**Humanin can serve as a practical biomarker for selecting high-quality, freezeable semen** in crossbred cattle breeding programs. This finding offers a significant advancement for livestock reproduction, potentially …
Identifying an early and reliable biomarker for AKI after heart transplantation is critically important, as it could enable clinicians to intervene sooner, potentially preventing severe kidney damage and improving pat…
Understanding the precise role of Humanin in the context of cardiac surgery outcomes could significantly advance patient care and risk management. If specific Humanin levels are found to correlate with, or predict, th…
This review highlights a significant untapped area of research with profound implications for understanding and treating lung diseases. Given the established roles of MDPs in other complex diseases, their investigatio…
Free, no account — handy when you're working with Humanin.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$14 monthly or $88/year
Create an account